article · Mathematical Methods in the Applied Sciences
In this paper, we introduce an innovative hybrid discrete‐continuum model that provides a comprehensive framework for understanding the intricate interactions between tumor cells, immune cells, and the effects of immunotherapy. This study distinguishes itself by addressing the limitations of traditional diffusion models, which often fail to capture the irregular and nonlocal movements of cells within the complex tumor microenvironment. To overcome these challenges, we employ fractional time derivatives and the fractional Laplacian operator, offering a more accurate representation of anomalous diffusion processes that are critical in cancer dynamics. Our research begins with a rigorous mathematical analysis, where we establish the global existence of a unique mild solution, laying a solid theoretical foundation for the model. A key innovation of our study is the introduction of the “invasion threshold,” a critical parameter inspired by the next‐generation operator used in epidemiological modeling. This threshold provides a powerful tool for determining the existence and stability of equilibrium points, offering deep insights into the conditions that either promote or inhibit tumor growth under immunotherapeutic interventions. By integrating a hybrid discrete‐continuum approach, we capture the individual behavior of each cell, allowing for a more detailed exploration of the dynamic interplay within the tumor microenvironment. This model not only advances our understanding of tumor‐immune interactions but also holds potential for informing more effective therapeutic strategies, making a significant contribution to the field of mathematical oncology.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/mma.10595
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.